The Enterprise Value as of November 2025 (TTM) for Biocartis Group N.V. (BIOGF) is 124.67M

According to Biocartis Group N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 124.67M. This represents a change of -43.00% compared to the average of 218.70M of the last 4 quarters.

Biocartis Group N.V. (BIOGF) Historical Enterprise Value (quarterly & annually)

How has BIOGF Enterprise Value performed in the past?

The mean historical Enterprise Value of Biocartis Group N.V. over the last ten years is 441.68M. The current 124.67M Enterprise Value has changed 2.72% with respect to the historical average. Over the past ten years (40 quarters), BIOGF's Enterprise Value was at its highest in in the December 2014 quarter at 620.75M. The Enterprise Value was at its lowest in in the January 2012 quarter at 0.

Biocartis Group N.V. (BIOGF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Biocartis Group N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Biocartis Group N.V. (BIOGF) Average Enterprise Value

How has BIOGF Enterprise Value performed in the past?

The current Enterprise Value of Biocartis Group N.V. (BIOGF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Biocartis Group N.V. (BIOGF) Enterprise Value vs. Peers

How is BIOGF’s Enterprise Value compared to its peers?

Biocartis Group N.V.’s Enterprise Value is greater than Taihe Group, Inc. (71.89M), greater than Kiaro Holdings Corp. (7.23M), less than Elegance Optical International Holdings Limited (0), less than SymBio Pharmaceuticals Limited (3.12B), greater than RetinalGenix Technologies Inc. (59.59M), less than Goodness Growth Holdings, Inc. (128.04M), less than MCI Onehealth Technologies Inc. (0), greater than Karolinska Development AB (publ) (48.27M), greater than Herantis Pharma Oyj (51.38M), less than Oncopeptides AB (publ) (1.15B),

Build a custom stock screener for Biocartis Group N.V. (BIOGF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biocartis Group N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Biocartis Group N.V. (BIOGF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Biocartis Group N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.